InSilixa is a startup based in the United States, most recent round Acquired.
Based in the United States, InSilixa is a startup. InSilixa has been acquired.
InSilixa developed a mass-deployable, high-performance medical diagnostics technology platform that rapidly identifies pathogens in clinical samples and detects genetic mutations causing antibiotic resistance.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.